A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK4771261 in healthy participants and participants with autosomal dominant polycystic kidney disease.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516095-15-00

Acronym

221362

Enrollment

Registered

2025-04-30

Start date

2025-08-05

Completion date

Unknown

Last updated

2025-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Disease

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium, France, Germany, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026